CME Group (CME): Director filed to sell ~$163K
Kaye Daniel G, Director at CME Group, filed to sell ~$163K of CME Group shares.
- ~$163K
- planned to sell · 532 shares, around Nov 9, 2026
- Planned for
- Nov 9, 2026
- Notice filed
- Nov 9, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Sep 10, 2026Insider · 1 personInsiders: 2 sales (~$4.1M)
- Sep 14, 2026InsiderDirector sold ~$140K of CME shares in the open market
- Sep 24, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
- Oct 21, 2026Company filing · Form 8-K · ResultsReported its results
- Oct 22, 2026InsiderDirector sold ~$121K of CME shares in the open market
- Oct 27, 2026InsiderOfficer sold ~$1.49M of CME shares in the open market
- Nov 2, 2026Insider · 2 peopleInsiders: 2 sales (~$3.7M)
- Nov 9, 2026InsiderDirector sold ~$162K of CME shares in the open market
How to read SEC Form 144
Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.
Full guide: What is an SEC Form 144?
What else is on file for CME Group
For CME Group, OQRO holds 16 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CME page.
How this filing works
Explore the data
Other disclosures at CME Group
- SEC Form 13F-HRNov 13, 2026
- SEC Form 4Nov 10, 2026
- SEC Form 4Nov 3, 2026
- SEC Form 4Nov 3, 2026
- SEC Form 144Nov 2, 2026
- SEC Form 144Nov 2, 2026
Everything OQRO holds on this company is on its CME page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
